• Thu, November 11, 2021
Arvind Ramnani Maintained (BLND) at Buy with Decreased Target to $19 on, Nov 11th, 2021
Arvind Ramnani of Piper Sandler, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $24 to $19 on, Nov 11th, 2021.
Arvind has made no other calls on BLND in the last 4 months.
There are 8 other peers that have a rating on BLND. Out of the 8 peers that are also analyzing BLND, 1 agrees with Arvind's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Karl Keirstead of "UBS" Initiated at Hold and Held Target at $20 on, Tuesday, August 10th, 2021
These are the ratings of the 7 analyists that currently disagree with Arvind
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $22 on, Friday, August 20th, 2021
- Justin Patterson of "Piper Sandler" Initiated at Buy and Held Target at $24 on, Tuesday, August 10th, 2021
- Michael Ng of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Tuesday, August 10th, 2021
- Michael Turrin of "Wells Fargo" Initiated at Buy and Held Target at $24 on, Tuesday, August 10th, 2021
- Terry Tillman of "Truist Securities" Initiated at Strong Buy and Held Target at $24 on, Tuesday, August 10th, 2021
- Bhavan Suri of "William Blair" Initiated at Buy on, Tuesday, August 10th, 2021
- Joseph Vafi of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $28 on, Tuesday, August 10th, 2021
Like: 👍
